You are here: All Products  > Tyligand Starts US Trial of KRAS G12D Inhibitor for Solid Tumor Cancers

Tyligand Starts US Trial of KRAS G12D Inhibitor for Solid Tumor Cancers

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products